台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    60.9
  • 漲跌
    ▲1.2
  • 漲幅
    +2.01%
  • 成交量
    158
  • 產業
    上櫃 生技醫療類股
  • 69人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
易威 (1799)籌碼相關-元富-成功 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-成功 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/31164.1000.0064.3016690.15%
2024/12/3000.00068.0066.7006920.00%
2024/12/26168.5000.0066.6016920.14%
2024/12/2400.00173.0073.00-1677-0.15%
2024/12/19161.0000.0062.7016950.14%
2024/11/2000.000.268.2567.40-0.2666-0.03%
2024/11/13167.4000.0064.0016520.15%
2024/11/0600.001286.9385.20-12634-1.89%
2024/11/05385.13184.0084.9026360.31%
2024/11/04490.6800.0091.8046370.63%
2024/10/30293.9500.0093.8026700.30%
2024/10/28395.8700.0095.5036880.44%
2024/10/253100.1700.00100.0036870.44%
2024/10/2300.001103.00104.00-1710-0.14%
2024/10/222105.2500.00107.0027260.28%
2024/10/181113.0000.00110.0017680.13%
2024/10/1700.001118.00122.00-1779-0.13%
2024/10/151117.5000.00117.0018110.12%
2024/10/0800.004.1127.01126.00-4.1839-0.48%
2024/10/0700.001112.00116.50-1830-0.12%
2024/10/0400.000.2106.25106.50-0.2813-0.02%
2024/10/01297.2000.0097.2027870.25%
2024/09/273122.5000.00120.0037960.38%
2024/09/262133.7500.00133.0027850.25%
2024/09/251145.500158.50147.5017840.13%
2024/09/240163.501.4163.00159.00-1.4789-0.18%
2024/09/231160.0000.00158.0017940.13%
2024/09/0600.0014.6201.09195.00-14.6800-1.83%
2024/08/2300.000.1228.00229.00-0.1798-0.01%
2024/08/1900.000.1202.50201.50-0.1820-0.01%
2024/08/091204.502203.00203.50-1824-0.12%
2024/08/070.1176.0000.00180.000.17810.01%
2024/08/060.5173.2700.00171.000.57770.06%
2024/08/0500.001173.00180.00-1768-0.13%
2024/07/1900.000187.00182.0006500.00%
2024/07/180195.001196.00196.50-1611-0.16%
2024/07/171179.5000.00191.0015890.17%
2024/07/0400.000126.00126.0004770.00%
2024/07/030127.0000.00124.5004740.00%
2024/07/0100.000138.00137.5004350.00%
2024/06/2800.001130.00130.00-1413-0.24%
2024/06/2700.003108.17118.50-3393-0.76%
2024/06/260103.005103.60108.00-5378-1.32%
2024/06/2400.005107.40103.00-5368-1.36%
2024/06/210107.501107.50106.00-1368-0.27%
2024/06/2000.007105.07105.00-7372-1.88%
2024/06/1800.001104.50104.50-1364-0.27%
2024/06/171106.5000.00108.0013530.28%
2024/06/1200.00197.4097.40-1327-0.31%
2024/06/115101.6000.00101.5053241.54%
2024/06/07896.14198.1098.1073202.19%
2024/06/06196.1000.0095.0013180.31%
2024/06/04192.3000.0096.0013160.32%
2024/05/31392.2300.0091.8033170.94%
2024/05/30393.5000.0090.9033200.94%
2024/05/242100.0000.00105.0022980.67%
2024/05/2300.000.4100.50100.50-0.4286-0.14%
2024/05/2100.000.188.0093.00-0.1250-0.04%
2024/05/0800.00278.0078.20-2267-0.75%
2024/04/2900.000.466.4067.50-0.4252-0.16%
2024/04/24168.6000.0067.7012570.39%
2024/04/23164.3000.0068.0012560.39%
2024/04/22265.4500.0064.5022530.79%
2024/04/1700.00166.6067.00-1253-0.39%
2024/04/01269.5000.0069.9022470.81%
2024/03/0400.00260.0060.20-2193-1.03%
2024/02/2000.00148.8048.30-1180-0.55%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音